Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,363 | -50,688 | -26,690 | 21,044 | 84,090 |
| Depreciation Amortization | 993 | 7,204 | 5,624 | 3,149 | 1,537 |
| Accounts receivable | -10,380 | -24,240 | -19,523 | -12,563 | -7,050 |
| Other Working Capital | -16,774 | -97,461 | -78,963 | -59,126 | -24,794 |
| Other Operating Activity | 25,856 | -66,811 | -81,386 | -95,539 | -111,671 |
| Operating Cash Flow | $-35,668 | $-231,996 | $-200,938 | $-143,035 | $-57,888 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,421 | -293,295 | 195,877 | 63,173 | 80,000 |
| PPE Investments | -12,166 | -12,000 | -8,101 | -7,336 | -4,465 |
| Sale Of Investment | N/A | 10,695 | 10,695 | 10,695 | 10,695 |
| Purchase Sale Intangibles | -673 | 115,785 | 116,409 | 123,399 | 123,755 |
| Other Investing Activity | -673 | 115,785 | 116,409 | 123,399 | 123,755 |
| Investing Cash Flow | $-14,260 | $-178,815 | $314,880 | $189,931 | $209,985 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 96,235 | 69,708 | 53,620 | 0 | 0 |
| Debt Repayment | -101,407 | -54,754 | -38,089 | -5,054 | -2,543 |
| Common Stock Issued | 12,643 | 369,183 | 365,738 | 4,086 | 2,749 |
| Other Financing Activity | 0 | 503,945 | 0 | 0 | 0 |
| Financing Cash Flow | $7,471 | $888,082 | $381,269 | $-968 | $206 |
| Beginning Cash Position | 599,827 | 122,556 | 122,556 | 122,556 | 122,556 |
| End Cash Position | 557,370 | 599,827 | 617,767 | 168,484 | 274,859 |
| Net Cash Flow | $-42,457 | $477,271 | $495,211 | $45,928 | $152,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,668 | -231,996 | -200,938 | -143,035 | -57,888 |
| Capital Expenditure | -12,166 | -12,000 | -8,101 | -7,336 | -4,465 |
| Free Cash Flow | -47,834 | -243,996 | -209,039 | -150,371 | -62,353 |